Diagnosis and therapy of bee and wasp venom allergies - A position paper of the German Society for Allergology and Clinical Immunology;Diagnose und therapie der Bienen- und Wespengiftallergie: Positionspapier der Deutschen Gesellschaft fur Allergologie und klinische Immunologie (DGAI)

Allergo Journal

Volumn 9, Issue 8, 2000, Pages 458-472

  Rueff, F ^a   Przybilla, B ^a   Fuchs, T ^a   Gall, H ^a   Rakoski, J ^a   Stolz, W ^a   Vieluf, D ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

Diagnosis specific IgE; Hyposensitization; Insect venom allergy; Prick test; Risks; Sting challenge; Treatment

Indexed keywords

ANTIHISTAMINIC AGENT; BEE VENOM; CORTICOSTEROID; WASP VENOM;

ANAPHYLAXIS; ANTIBODY SPECIFICITY; BEE STING; HUMAN; IMMUNOTHERAPY; INSECT ALLERGY; PRICK TEST; PROVOCATION TEST; REVIEW; RISK FACTOR;

EID: 0033665957     PISSN: 09418849     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (67)

1. Position statement: Beta-adrenergic blockers
2. Anaphylaktoide reaktionen bei patienten mit ACE-hemmer-behandlung bei gleichzeitiger desensibilisierungsbehandlung oder nach insektenstichen. Arzneimittel-schnellinformation des bundesinstitutes fur arzneimittel und medizinprodukte
3. Hymenopterengift-allergie. Stellenwert des allergen-spezifischen IgG bei der therapie
4. The evaluation of the common diagnostic methods of hypersensitivity for bee and yellow jacket venom by means of an in-hospital sting
5. Systemic reactions during maintenance immunotherapy with honey bee venom
6. Evolution of sensitivity to hymenoptera venom in 200 allergic patients followed for up to 3 years
7. WHO position paper. Allergen immunotherapy: Therapeutic vaccines for allergic disease
8. Efficacy of antihistamine treatment in the prevention of adverse reactions to Hymeno-ptera immunotherapy: A prospective, randomized, placebo-controlled trial
9. Serum sickness after wasp venom immunotherapy: Clinical and biological study
10. Successful ultra-rush specific immunotherapy of two patients with Honeybee venom allergy confirmed by sting challenge test
11. Infantile multicystic encephalomalacia after maternal bee sting a naphylaxis during pregnancing
12. Diagnostische Stichprovokation
13. Lack of reproducibility of a single negative sting challenge response in the assessment of a naphylactic risk in patients with suspected yellow jacket hypersensitivity
14. Tod nach Wespenstich als Berufsunfall - Ein Begutachtungsproblem
15. Reduktion der Nebenwirkungen bei der Immuntherapie mit Insektengiften unter Antihistaminika-Schutz
16. Timing of venom skin tests and IgE determinations after insect sting anaphylaxis
17. Dose-dependence of hymenoptera venom immunotherapy
18. Epidemiology of insect venom sensitivity
19. Subsequent insect stings in children with hypersensitivity to hymenoptera
20. Hymenopterengiftallergie: Hyposensibilisierungstherapie trotz vorhandener Kontraindikationen
21. Provocation test with a living insect as a diagnostic tool in systemic reactions to bee and wasp venom: A prospective study with emphasis on the clinical aspects
22. Hyposensibilisierung mit insektengiftextrakten bei pateinten mit hymenopterengift-allergie im hoheren lebensalter
23. Delayed toxic reaction following massive bee envenomation
24. Multiple hornet (Vespa orientalis) stings with fatal outcome in a child
25. Clinical and immunological features and subsequent course of patients with severe insectsting anaphylaxis
26. Long-term protection after stopping venom immuno-therapy: Results of re-stings in 200 patients
27. Clinical application of measurements of serum levels of bee venomspecific IgE and IgG
28. Immunotherapy. Position paper of the European Academy of allergology and clinical immunology
29. Zur kausalen Behandlung der Hymenopterenstichallergie
30. Immunotherapy with yellow jacket venom
31. Predictive value of venom specific IgE, IgG and IgG subclass antibodies in patients on immunotherapy with honey bee venom
32. Honey bee venom allergy: Results of a sting challenge 1 year after stopping successful immunotherapy in 86 patients
33. Emergency treatment of allergic reactions to hymenoptera stings
34. Immunotherapy with honeybee venom and yellow jacket venom is different regarding efficacy and safety
35. Position paper: Immunotherapy with hymenoptera venoms
36. Adrenaline for emergency kits
37. Diagnostik und therapie der bienen- und wespengiftallergie
38. Fatal a naphylaxis after a yellow jacket sting, despite venom immuno-therapy, in two patients with mastocytosis
39. Evaluation of hymenoptera-sting sensitivity with deliberate sting challenges: Inadequacy of present diagnostic methods
40. Hymenoptera venom study (HVS), treatment results
41. Muckenstichallergie
42. Schnellhyposensi-bilisierung mit hymenopterengiften. Vertraglichkeit und therapieerfolg
43. Die indikation zur hymenopterengift-hypo-sensibilisierung kann nicht anhand eines diagnostischen parameter bewerten-den punkteschemas gestellt werden
44. Late-onset allergic reactions, including serum sickness, after insect stings
45. Natural history of insect-sting allergy: Relationship of severity of symptoms of initial sting anaphy laxis to re-sting reactions
46. Immunology and treatment of mosquito bites
47. Insektengift-Allergie
48. Schnellhyposensibilisierung bei insektengiftallergie: Noch aktuell?
49. The sting challenge test in hymenoptera venom allergy
50. Nebenwirkungen der schnellhyposensi-bilisierung mit hymenopterengift
51. Efficacy and safety of honeybee venom (HBV) immunotherapy with an aquous (AE) and an aluminium hydroxide adsorbed depot extract (DE)
52. Clinical characteristics of patients with repeated systemic reactions during specific immunotherapy with Hymenoptera venoms. A retrospective study
53. IgE antibodies to hymenoptera venoms in the serum are common in the general population and are related to indications of atopy
54. Rate and quantity of delivery of venom from honeybee stings
55. Venom immunotherapy in the hymenoptera-allergic pregnant patient
56. Venom-specific IgE antibodies in postmortem sera from victims of sudden, unexpected death
57. Risk of anaphylaxis in patients receiving beta-blocker drugs
58. Akuttherapie anaphylaktoider reaktionen. Ergebnisse einer interdisziplinaren konsensus-konferenz
59. Invasion of the 'killer' bees. Separating fact from fiction
60. Discontinuation of bee venom immunotherapy in children and adolescents
61. The value of immunotherapy with venom in children with allergy to insect stings
62. Insect-sting challenge in 324 subjects with a previous anaphylactic reaction: Current criteria for insect-venom hypersensitivity do not predict the occurrence and the severity of anaphylaxis
63. Hyposensitisation to wasp venom in six hours
64. Multiple hornet stings with features of Reye's syndrome
65. Rush venom immuno-therapy program for honeybee sting sensitivity